Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jesús Sepúlveda-Méndez"'
Autor:
Juan Carlos Rojas-Bautista, Ofelia González-Treviño, Consuelo Arteaga de Murphy, Eduardo Murphy-Stack, Martha Pedraza-López, Jesús Sepúlveda-Méndez
Publikováno v:
Nuclear Medicine Communications. 33:69-79
OBJECTIVES Gastroenteropancreatic neuroendocrine tumors (NETs) are cancers originating from neuroendocrine organs such as the pancreas, pituitary, thyroid, and adrenal glands and tumors arising from the diffuse neuroendocrine cells that are widely di
Autor:
Jesús, Sepúlveda-Méndez, Consuelo Arteaga, de Murphy, Martha, Pedraza-López, Eduardo, Murphy-Stack, Juan Carlos, Rojas-Bautista, Ofelia, González-Treviño
Publikováno v:
Nuclear medicine communications. 33(1)
Gastroenteropancreatic neuroendocrine tumors (NETs) are cancers originating from neuroendocrine organs such as the pancreas, pituitary, thyroid, and adrenal glands and tumors arising from the diffuse neuroendocrine cells that are widely distributed t
Autor:
Juan Carlos Rojas-Bautista, Martha Pedraza-López, Jesús Sepúlveda-Méndez, Consuelo Arteaga de Murphy
Publikováno v:
Nuclear medicine communications. 31(10)
UNLABELLED: Fever of unknown origin (FUO) represents a challenge to clinical medicine, and bacterial cultures have been considered the 'gold standard' in discriminating between fevers resulting from bacterial infection and sterile inflammations. In n
Autor:
Heriberto Medina-Franco, José L. Ulloa-Gómez, Jesús Sepúlveda-Méndez, Miriam N. García-Alvarez, Cecilia Romero-Trejo, Leonardo Abarca-Pérez
Publikováno v:
Journal of surgical oncology. 97(2)
Background It is important to optimize the localization technique for non-palpable breast lesions. Methods One hundred consecutive women with non-palpable breast lesions were randomized to radioguided occult lesion localization (ROLL) or wire localiz
Autor:
Carlos E. Montoya-Molina, Laura Meléndez-Alafort, Jesús Sepúlveda-Méndez, Consuelo Arteaga de Murphy
Publikováno v:
Nuclear medicine and biology. 24(1)
Technetium-99m-labeled alendronate is a new radiopharmaceutical for bone scanning developed under strict quality control at the INNSZ. The purpose of this work was to compare the radiopharmacokinetic data and the dosimetry of 99mTc-ABP and 99mTc-MDP
Autor:
Guillermina Ferro-Flores, Lauro Reyes-Herrera, Jesús Sepúlveda-Méndez, Eva María Molina-Trinidad, Benjamı́n Sandoval-Guzmán, Consuelo Arteaga de Murphy, Carlos Hoyo-Vadillo, Laura Meléndez-Alafort
Publikováno v:
ResearcherID
Background Technetium-99m-mercaptoacetyltriglycine ( 99m Tc-MAG 3 ) is a radiopharmaceutical for tubular function and can be prepared with 99m-technetium and the ligand Bz-MAG 3 (Instituto Nacional de Investigaciones Nucleares, Mexico City). No radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf2b864e9bb09554b367ad7d997e29f
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10071425
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10071425